MUNDIPHARMA MEDICAL COMPANY LIMITED
Company Information
- Company Number
- 09273950
- Registered Address
- Unit 196 Cambridge Science Park, Milton Road, Cambridge, England, CB4 0AB
- Status
- Active
- Employee Count
- 106
- Turnover
- £426,117,000
- EBITDA
- £79,793,000
Additional Details
- Website
- https://mundipharma.com
- Company Type
- Private limited Company
- Incorporated On
- 21 October 2014
- Nature of Business
- 46460 - Wholesale of pharmaceutical goods
- Industries
- Coming Soon
- Region
- East of England
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 06 Aug 2025 | 98 | 31% | 28% | 41% | 60% |
| 01 Jul 2024 - 31 Dec 2024 | 19 Feb 2025 | 97 | 40% | 20% | 40% | 55% |
| 01 Jul 2023 - 31 Dec 2023 | 31 Jan 2024 | 34 | 57% | 32% | 11% | 41% |
| 01 Jul 2021 - 31 Dec 2021 | 30 Jan 2022 | 43 | 38% | 50% | 13% | 64% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 77 | 30% | 37% | 32% | 60% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 90 | 31% | 27% | 42% | 70% |
| 01 Jan 2019 - 30 Jun 2019 | 24 Jul 2019 | 36 | 66% | 26% | 8% | 24% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 32 | 77% | 17% | 6% | 17% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 33 | 73% | 20% | 7% | 23% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
The default position is 90 days, however there may be changes to this default position on a case-by-case basis pending agreement with suppliers. On a case-by-case basis, payment terms to suppliers may be immediate payment or payment on terms within 7, 14, 30 or 60 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
If a supplier has a query or dispute relating to a payment they believe is owed to them by Mundipharma Medical Company Limited (MMCL) the supplier is to please email the below details to MMCL.APQueries@mundipharma.com: a. Full supplier name, address; b. The name of your MMCL point of contact; c. Invoice number for the payment you are querying; d. Full details of your complaint; e. Upon receipt of all of the above details, MMCL commits to acknowledge receipt of the supplier email within five working days, and may request further information to be able to respond in full. MMCL will investigate the supplier query using the details provided and speak with relevant members of MMCL’s business, including members of MMCL’s legal department if necessary, and respond in full within 14 days of the date of MMCL’s acknowledgement to the supplier.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
MUNDIPHARMA MEDICAL COMPANY LIMITED is a global pharmaceutical company that is committed to developing and providing innovative and sustainable healthcare solutions. The company was founded in 1952 and has since expanded its operations to over 60 countries worldwide.
The company's sustainability program focuses on reducing their environmental impact and promoting social responsibility. They have implemented various initiatives such as reducing their carbon footprint, promoting sustainable sourcing of materials, and supporting local communities through their corporate social responsibility projects.
MUNDIPHARMA offers a wide range of prescription medicines, over-the-counter products, and medical devices in various therapeutic areas such as pain management, respiratory diseases, and oncology. Their products are developed using advanced technologies and are known for their high quality and effectiveness.
The key people at MUNDIPHARMA include the CEO, Raman Singh, who has over 20 years of experience in the pharmaceutical industry, and the Chief Medical Officer, Dr. Gerd Zettlmeissl, who has a background in clinical research and development.
To contact MUNDIPHARMA, individuals can visit their website at https://www.mundipharma.com/ or reach out to their registered office at Mundipharma House, Millbank, London SW1P 4QP, United Kingdom. The company also has various global offices and can be contacted through their local websites.
